Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
  • Careers & studies
        • Careers & Studies

          Take the next step in your career with Centenary, Australia’s foremost clinically integrated medical research institute

          Learn more

        • Career opportunities
        • Life at Centenary
        • Post-Doctorate Research
        • PhD
        • Masters
        • Honours
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Contact
  • Donate
    Centenary Institute > People > Professor Philip Hansbro

Professor Philip Hansbro

Deputy Director, Centenary Institute;
Director, Centenary UTS Centre for Inflammation

Programs

  • Centenary UTS Centre for Inflammation

Phone number Phone Number +61 2 9565 6248

Email Email p.hansbro@centenary.org.au

Profile Linkedin Profile

Professor Phil Hansbro is an internationally recognised research leader in the study of respiratory diseases, such as asthma, chronic obstructive airway disease (COPD, aka emphysema) and infections and is developing interests in lung cancer. His work is substantially contributing to understanding the pathogenesis and developing new therapies for these diseases.

His work has made internationally important contributions and led to the identification of novel avenues for therapy that are under further study. This is achieved through the development of novel mouse models that recapitulate the hallmark features of human disease, including infections, asthma and COPD and now lung cancer. He employs these models in integrated approaches (infection, immunity and physiology with particular expertise in lung function analysis) to understand human diseases, and develop new treatment strategies. Research outcomes have a translational goal and his studies are conducted in parallel with collaborative human studies with clinical researchers.

Research

  • Centenary UTS Centre for Inflammation

    Inflammation is increasingly being found to play crucial roles in the development of many major diseases, i­ncluding Alzheimer’s, heart disease, cancer, respiratory diseases, diabetes, tuberculosis and COVID-19. The Centenary UTS Centre for Inflammation (CFI) is Australia’s first research centre dedicated exclusively to studying the mechanisms underlying inflammation, to understand how specific diseases develop and progress and can be treated.
    Read more

Themes

  • Cancer

    Cancer
  • Inflammation

    Inflammation

Research Fields

  • Asthma
  • COPD – Chronic obstructive pulmonary disease
  • Lung Cancer

Topics

  • Chronic diseases ,

Publications

Recent publications

Search amongst our repository

all publications

For access to all Publications via Pub Med.

Research

  • Centenary UTS Centre for Inflammation

    Inflammation is increasingly being found to play crucial roles in the development of many major diseases, i­ncluding Alzheimer’s, heart disease, cancer, respiratory diseases, diabetes, tuberculosis and COVID-19. The Centenary UTS Centre for Inflammation (CFI) is Australia’s first research centre dedicated exclusively to studying the mechanisms underlying inflammation, to understand how specific diseases develop and progress and can be treated.
    Read more

News

  • World-first study reveals why people with COPD are more susceptible to COVID-19

    Researchers from the Centenary Institute and the University of Technology Sydney have published the first study showing why people with chronic obstructive pulmonary disease (COPD) are at higher risk of developing severe COVID-19. The findings, reported in the American Journal of Respiratory and Critical Care Medicine,could lead to the development of new therapeutic interventions that ...
    Date 17 May 2022
  • SMH (Good Weekend article) features Professor Phil Hansbro

    Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation has featured in a Good Weekend article discussing the role of inflammation in health. Inflammation is increasingly being found to play crucial roles in the development of many major diseases, including Alzheimer’s, heart disease, cancer, respiratory diseases, diabetes, tuberculosis and COVID-19. “There’s been a ...
    Date 28 Feb 2022
  • Researchers find new target to combat lung disease

    Research led by the Centenary Institute and University of Technology Sydney has identified a small RNA molecule called microRNA-21 as a therapeutic target and its inhibition as a potential treatment for chronic obstructive pulmonary disease (COPD).
    Date 25 Nov 2021
  • Health impacts of climate change to be tackled by HEAL network

    Australians will be better protected against the health impacts of climate change, thanks to the Healthy Environments And Lives (HEAL) national research network, just announced by the Australian Government.
    Date 15 Nov 2021
  • $5M grant to investigate relationship between gut and lung in respiratory disease

    Australian researchers have been awarded a $5 million National Health and Medical Research Council (NHMRC) Synergy Grant for a project that will advance knowledge of the gut, microbiomes, metabolites and diet, and their role in both causing and potentially treating inflammatory respiratory diseases, particularly chronic obstructive pulmonary disease (COPD).
    Date 21 Oct 2021
  • Cell death discovery could lead to new treatment for COPD

    Research shows that inhibiting necroptosis, a form of cell death, could be a novel therapeutic approach for treating chronic obstructive pulmonary disease (COPD), an inflammatory lung condition, also known as emphysema, that makes it difficult to breathe.
    Date 16 Jun 2021
View all

Twitter

Tweets by CentenaryInst Follow us (links open in a new window)

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Laboratories
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram